GlassScriptPhysician profile
Austin J Ramme
NPI 1538429246
$12,119.20
in general payments reported to CMS, 2019-2025
11 companies · $262 in 2025
The $262 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $1,297 · 2021: $6,108 · 2022: $3,066 · 2023: $441 · 2024: $668 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727 · Travel and Lodging: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.22 |
| Travel and Lodging | $643.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wardlow Enterprises | $8,175.05 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $1,625.85 | 2022 | |
| Prism Medical | $643.85 | 2024 | |
| Arthrex, INC. | $545.20 | 2021-2024 | Arthrex |
| Medtronic, INC. | $335.55 | 2021-2025 | Activos 10 Bone Cement, Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Boston Scientific Corporation | $207.28 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Vericel Corporation | $174.29 | 2019-2023 | Maci |
| Stryker Corporation | $134.63 | 2019-2023 | Inspace |
| Djo, LLC | $134.47 | 2019 | |
| Medical Device Business Services, INC. | $128.65 | 2025 | Velys, Attune, Actis |
| Biotronik Nro, INC. | $14.38 | 2023 | Biotronik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Ramme listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.